Listed

XORTX Therapeutics Inc.

XRTXNasdaqCIK 1729214HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsCAD 18.9m, FY2021
Shareholders' equityCAD 16.7m, FY2021
Line itemUnitperiod not labelled2018-12-31period not labelled2019-12-31period not labelled2020-12-31FY20212021-12-31
Cash and equivalents$m0.3Cash and equivalents, period not labelled, at 2018-12-31CAD 260.0k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure0.1Cash and equivalents, period not labelled, at 2019-12-31CAD 58.6k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure0.2Cash and equivalents, period not labelled, at 2020-12-31CAD 171.3k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure18.9Cash and equivalents, FY2021, at 2021-12-31CAD 18.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure
Current assets$mnot reportednot reported2.1Current assets, period not labelled, at 2020-12-31CAD 2.1m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure20.2Current assets, FY2021, at 2021-12-31CAD 20.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure
Total assets$mnot reportednot reported2.3Total assets, period not labelled, at 2020-12-31CAD 2.3m. XBRL concept ifrs-full:Assets. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure22.0Total assets, FY2021, at 2021-12-31CAD 22.0m. XBRL concept ifrs-full:Assets. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure
Current liabilities$mnot reportednot reported1.0Current liabilities, period not labelled, at 2020-12-31CAD 1.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure0.7Current liabilities, FY2021, at 2021-12-31CAD 701.0k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure
Total liabilities$mnot reportednot reported1.0Total liabilities, period not labelled, at 2020-12-31CAD 1.0m. XBRL concept ifrs-full:Liabilities. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure5.3Total liabilities, FY2021, at 2021-12-31CAD 5.3m. XBRL concept ifrs-full:Liabilities. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure
Shareholders' equity$m0.3Shareholders' equity, period not labelled, at 2018-12-31CAD 321.5k. XBRL concept ifrs-full:Equity. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure(0.2)Shareholders' equity, period not labelled, at 2019-12-31−CAD 211.7k. XBRL concept ifrs-full:Equity. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure1.3Shareholders' equity, period not labelled, at 2020-12-31CAD 1.3m. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure16.7Shareholders' equity, FY2021, at 2021-12-31CAD 16.7m. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2022-05-03, accession 0001753926-22-000646.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.